|
New York Memorial Sloan-Kettering Cancer Center, New York News is an EIN News Service for health professionals. Constantly updated news and information about New York Health.
Latest New York Memorial Sloan-Kettering Cancer Center, New York News
- New Cancer Target For Non-Hodgkin's Lymphoma Featured In Nature Medicine 25 Nov 2009 11:51 GMT
... was developed by Dr. Gabriela Chiosis, a principal author of the study, from the Memorial Sloan-Kettering Cancer Center, in New York City. The scientific team discovered that exposing lymphoma cells to PU-H71 in laboratory experiments ...
- Upcoming Clinical Trial Of New Cancer Target For Non-Hodgkin's Lymphoma 25 Nov 2009 08:47 GMT
... was developed by Dr. Gabriela Chiosis, a principal author of the study, from the Memorial Sloan-Kettering Cancer Center, in New York City. The scientific team discovered that exposing lymphoma cells to PU-H71 in laboratory experiments ...
- Stone Point Capital Foundation Raises Over $500,000 for Rare Liver Cancer Research 24 Nov 2009 21:10 GMT
... of General Surgical Oncology and Director of the General Surgical Oncology Fellowship Program at Memorial Sloan-Kettering Cancer Center in New York City, and Dr. Sidransky is the Director of Head and Neck Cancer Research in ...
- Artel to Launch New Technology at LabAutomation2010 24 Nov 2009 14:12 GMT
... Celgene, Centers for Disease Control, DuPont, Eli Lilly, FBI, Genentech, Genomic Health, Mayo Clinic, Memorial Sloan-Kettering Cancer Center, Merck, Pfizer, Procter & Gamble and U.S. FDA depends on Artel technology to ...
- Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging 24 Nov 2009 08:25 GMT
... Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room C-278, New York, NY 10065, USA. To assess the diagnostic accuracy of endorectal magnetic resonance (MR) imaging ...
- Mammogram mess-up: ObamaCare goes bust 24 Nov 2009 04:33 GMT
... many doctors who think that this new breast-cancer testing guideline from the federal task force ... for an oncologist who was associated with Memorial Sloan-Kettering Cancer Center years ago before mammograms were ...
- Novel therapeutic target for non-Hodgkin's lymphoma identified 23 Nov 2009 22:00 GMT
... Novel therapeutic target for non-Hodgkin's lymphoma identified November 23rd, 2009 - 4:18 ... author of the study, from the Memorial Sloan-Kettering Cancer Centre, in New York City. “We observed almost complete tumour regression ...
- NCCN Emphasizes Tailored Treatment in Discovery Health Channel Program Metastatic Breast Cancer: Ind 23 Nov 2009 20:26 GMT
... Northwestern University -- Beryl McCormick, MD - Memorial Sloan-Kettering Cancer Center -- John H. Ward, MD ... University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & ...
- NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 23 Nov 2009 19:41 GMT
... Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; The Ohio State ...
- How yoga helps cancer patients 23 Nov 2009 19:26 GMT
... Dana-Farber Cancer Institute, Memorial Sloan-Kettering, MC Anderson and other major for their cancer patients. Yoga uses breathing exercises, precise ...
- New Cancer Target for Non-Hodgkin's Lymphoma 23 Nov 2009 14:16 GMT
... was developed by Dr. Gabriela Chiosis, a principal author of the study, from the Memorial Sloan-Kettering Cancer Center, in New York City. The scientific team discovered that exposing lymphoma cells to PU-H71 in laboratory experiments ...
- Dr. Songlin Liang, MD, Ph.D., Honored by Cambridge Who's Who 23 Nov 2009 12:50 GMT
... full-service anatomic and cytopathology facility that services hospitals in the Central Valley of California. In ... fellowship in oncologic pathology in 2005 at Memorial Sloan-Kettering Cancer Center and his residency in 2004 ...
- Cytheris Announces Initiation of NCI/NIH-Sponsored Phase I/IIa Clinical Study of Tumor Vaccination and Interleukin-7 (IL 23 Nov 2009 11:35 GMT
... cell transplant to restore CD4+ and CD8+ counts following T-cell depletion, conducted at the Memorial Sloan-Kettering Cancer Center in New York City. a Phase I/IIa open-label, single arm clinical trial evaluating the safety profile of ...
- Cytheris Announces Initiation of NCI/NIH-Sponsored Phase I/IIa Clinical Study of Tumor Vaccination and Interleukin-7 (IL-7) in Patients with High Risk Pediatric Solid Tumors 23 Nov 2009 11:11 GMT
... cell transplant to restore CD4+ and CD8+ counts following T-cell depletion, conducted at the Memorial Sloan-Kettering Cancer Center in New York City. a Phase I/IIa open-label, single arm clinical trial evaluating the safety profile of ...
- Novel therapeutic target for non-Hodgkin's lymphoma identified 23 Nov 2009 10:56 GMT
... Washington, Nov 23 (ANI): Scientists from Weill Cornell Medical College claim to have ... author of the study, from the Memorial Sloan-Kettering Cancer Centre, in New York City. "We observed almost complete tumour regression ...
Powered by 
New York Health News Sections
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
>
Memorial Sloan-Kettering Cancer Center, New York
reuters.com:
ap.org:
msnbc.msn.com:
healthday.com:
bbc.co.uk: